High expression of CDK6 protects breast cancer cells from fulvestrant-mediated apoptosis and is a predictor of resistance to fulvestrant treatment in estrogen receptor-positive metastatic breast cancer

Carla Maria Lourenco Alves, Daniel Elias, Maria Bibi Lyng, Martin Bak, Anne Lykkesfeldt, Henrik Ditzel

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdato2015
StatusUdgivet - 2015
BegivenhedAACR-NCI-EORTC SYMPOSIUM: Molecular Targets and Cancer Therapeutics - Boston, MA, USA
Varighed: 5. nov. 20159. nov. 2015

Konference

KonferenceAACR-NCI-EORTC SYMPOSIUM: Molecular Targets and Cancer Therapeutics
LandUSA
ByBoston, MA
Periode05/11/201509/11/2015

Citationsformater

Alves, C. M. L., Elias, D., Lyng, M. B., Bak, M., Lykkesfeldt, A., & Ditzel, H. (2015). High expression of CDK6 protects breast cancer cells from fulvestrant-mediated apoptosis and is a predictor of resistance to fulvestrant treatment in estrogen receptor-positive metastatic breast cancer. Poster session præsenteret på AACR-NCI-EORTC SYMPOSIUM: Molecular Targets and Cancer Therapeutics , Boston, MA, USA.